This document contains general information about the CCI application form and specific information for individual sections and questions in the form.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2022-23.
Details of OGTR monitoring and compliance activities during the quarter ended 30 September 2023.
Limited and controlled release of white clover genetically modified for increased condensed tannins
Limited and controlled release of wheat and barley genetically modified for yield enhancement
This issue focuses on the updated CCI application form and the updated Notification of Minor Works form.
Regulatory approvals for activities with GMOs include two licence types based on whether or not they involve an intentional release of the GMO into the environment. Here is an explanation of what this means.
Misinformation has been circulating about the regulation of the Pfizer and Moderna mRNA COVID-19 vaccines. The following statement addresses this misinformation.
Limited and controlled release of cotton genetically modified for herbicide tolerance and insect resistance
Commercial supply of a live attenuated vaccine containing canine distemper virus and a genetically modified canine parvovirus (Nobivac Puppy DP Plus) for dogs